- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 8, 2026 | 13.43M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 13.34M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 12.2M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $17.49M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $18.97M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $791.43M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $36.55M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $31.81M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $12.23M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $12.11M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $828M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $834.7M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $878.63M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $885.23M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.17 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.13 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.17 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.13 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $2.52M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $2.06M |
| Net Income | Q1 2026 · Mar 31, 2026 | $2.28M |
| Net Income | Q1 2026 · Mar 31, 2025 | $1.58M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $22.14M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $20.21M |
| Revenue | Q1 2026 · Mar 31, 2026 | $39.98M |
| Revenue | Q1 2026 · Mar 31, 2025 | $37.33M |